With the EVIS EXERA III imaging platform, the PCF-H190TL/I is an HD device with a 510(k) claim for Narrow Band Imaging (NBI), which indicates NBI as a “highĬonfidence” assist to an experienced endoscopist employing a validated polyp classification system such as the NBI International Colorectal Endoscopic (NICE)Ĭlassification, aiding in distinguishing diminutive adenomatous polyps from non-adenomatous polyps during colonoscopy. The new PCF-H190TL/I endoscope is a slim, short-bending scope that allows for tighter angulation without compromise to the passage of treatment.“We know our physicianĬustomers are excited about these advancements that will improve their access and visualization of the anatomy as well as a growing range of treatment modalities.” “With these GI endoscopes, Olympus continues to raise the bar on increased functionality, bringing the market a slimmer diameter endoscope, all while providing imagingĮxcellence toward future innovations,” said Kevin Mancini, Vice President for Endoscopy at Olympus America Inc. Imaging modalities like Narrow Band Imaging (NBI), now available through a smaller diameter colonoscope, combine with capabilities such as retroflexion, to advance procedures The benefits of HQ Dual Focus imaging and Mucosal Resection and Endoscopic Submucosal Dissection, procedures that can benefit from the use of state-of-the-art endoscopes. Olympus is a market leader in products to enable minimally invasive treatments such as Endoscopic The products provide an extension to the existing capabilities for physicians to diagnose and treat disorders of the gastrointestinal tract. Caption: Olympus launches new colonoscopes to expand capability in minimally invasive procedures, including endoscopic submucosal dissection (ESD).ĬENTER VALLEY, Pa., (October 8, 2020) - Olympus announced today the 510(k) clearance and market availability of two colonoscopes, the
0 kommentar(er)
